Use: Labeled indications
- Use relieves redness of the eye due to minor eye irritation
Full indications and usage US FDA label
Use relieves redness of the eye due to minor eye irritation
Dosing: Adult
Dosage and administration (US label) US FDA label
Directions Instill 1 to 2 drops in the affected eye(s) up to 4 times daily
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Ophthalmic solution: 500 mcg/mL
Registered products in the Philippines
5 products registered with the Food and Drug Administration (FDA) Philippines list Tetrahydrozoline as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products5
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Eye Mo Cool Red EyesTetrahydrozoline Hydrochloride | 0.05% Solution (Eyedrops)HDPE bottle and cap with LDPE plug x 7.5 Ml (Box of 1's) | HR | PT. Pharma Health CareIndonesia | Integrated Market Services (Philippines) Inc. | DRHR-2428 | May 9, 2030 | |
Eye-Mo Red Eyes FormulaTetrahydrozoline Hydrochloride | 0.05% Ophthalmic Solution (Eye Drops)Plastic bottle x 7.5 ml and 15 mL (Box of 1's) | HR | PT. Pharma Health CareIndonesia | Importer: Integrated Market Services (Philippines) Inc. | DRHR-431 | May 14, 2027 | |
VisineTetrahydrozoline Hydrochloride | 500 mcg/mL (0.05% w/v) Ophthalmic Solution (Eye Drops)LDPE Plastic Bottle with PP cap x 6 mL (Box of 1's) | OTC | PT Pfizer IndonesiaIndonesia | Johnson & Johnson (Philippines), Inc. | DR-XY37227 | Jan 31, 2027 | |
VisineTetrahydrozoline HCl | 500 mcg/mL (0.05% w/v) Ophthalmic Solution (Eye Drops)LDPE Bottle x 15mL with PP Cap (Box of 1's) | OTC | Janssen Pharmaceutica NVBelgium | JNTL CONSUMER HEALTH (PHILIPPINES) INC. | DR-XY46844 | Mar 13, 2030 | |
VisineTetrahydrozoline Hydrochloride | 500mcg/mL (0.05% w/v) Ophthalmic Solution (Eye Drops)LDPE Bottle with Dropper Tip and White Cap x 15 mL (Box of 1's) | OTC | Janssen Pharmaceutica NVBelgium | Johnson & Johnson (Philippines), Inc. | DR-XY47700 | Feb 3, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
Warnings For external use only Ask a doctor before use if you have narrow angle glaucoma When using this product pupils may become enlarged temporarily to avoid contamination, do not touch tip of container to any surface. Replace cap after using. if solution changes color or becomes cloudy, do not use overuse may produce increased redness of the eye remove contact lens before using Stop use and ask a doctor if you experience eye pain changes in vision continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours If pregnant or breast-feeding, ask a health professional before use Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center [1-800-222-1222] right away.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. GoodSense Eye Drops Original Formula · Geiss, Destin & Dunn, Inc. [US FDA-approved label, version 3, December 30, 2025]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9b44de58-6362-3811-e053-2995a90a2f37
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .